BioAgilytix (NC, USA) and BRIO Systems (MA, USA) have launched COVIDenceTM, their complete COVID-19 workforce testing service for employers.
Charles River (MA, USA) have acquired Cellero (MA, USA) in a bid to enhance their cell therapy market solutions.
PerkinElmer, Inc. (MA, USA) have described their technology and research solutions available to their global customers in the fight against COVID-19.
Evaluation of stability using one versus three tubes for each quality control concentration in matrix-based bioanalysis
In this research article, the authors investigate the differences between two methods for matrix-based stability testing. This article is from the special focus issue published by Bioanalysis on Stability Issues in Bioanalysis.
Trajan Scientific and Medical (Melbourne, Australia) has listed its hemaPEN® blood microsampling device with the US FDA as Class I for therapeutic and in vitro diagnostic use.
Q2 Solutions (NC, USA) and LGC (Cambridge, UK) have announced a strategic global bioanalytical partnership between the two companies.
In our new Ask the Experts feature, we interviewed key figures from the pharmaceutical industry and CROs about their experiences and opinions on the various bioanalytical methods they use to quantify biologics by LC–MS.
In this feature we assess the global bioanalytical landscape in light of the draft ICH M10 bioanalytical method validation guideline published in 2019. Explore the impact of the draft guidance document through a selection of exclusive Bioanalysis journal and Bioanalysis Zone content.
In this supplement from Bioanalysis, the European Bioanalysis Forum reports its feedback to the ICH on the ICH M10 bioanalytical method validation draft guideline gathered during the public consultation period.
Thermo Fisher Scientific (MA, USA) are set to acquire Qiagen (Hilden, Germany), a provider of molecular diagnostics and sample preparation technologies, in an $11.5 billion transaction.